SCY-635

DRUG2 trials

Sponsors

Scynexis, Inc.

Conditions

Chronic Hepatitis CHepatitis C Infection

Phase 1

Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients

CompletedNCT01290965

Scynexis, Inc.Chronic Hepatitis C

Start: 2007-04-30End: 2009-01-31Updated: 2014-11-06

Phase 2

Study of SCY-635, Pegasys and Copegus in Hepatitis C

CompletedNCT01265511

Scynexis, Inc.Hepatitis C Infection

Start: 2010-11-30End: 2011-10-31Updated: 2017-08-18